You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polyclonal Antibody

Showing 1 - 25 of 5,613
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in New York (GIGA-2050)

Terminated
  • COVID-19
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jan 11, 2022

Advanced Solid Tumor, Metastatic Cancer Trial in Belgium, France (XON7)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Cancer
  • Anderlecht, Belgium
  • +3 more
Dec 1, 2023

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

Diabetes, Type 1, Diabetic Nephropathy Trial in Worldwide (sirolimus versus mycophenolate mofetil)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetic Nephropathy
  • sirolimus versus mycophenolate mofetil
  • Innsbruck, Austria
  • +13 more
Aug 17, 2021

Advanced Cancer Trial in Durham (pING-hHER3FL)

Recruiting
  • Advanced Cancer
  • pING-hHER3FL
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

Bloody Diarrhea, STEC, Unspecified, Hemolytic-Uremic Syndrome Trial in Argentina (INM004, Placebo)

Suspended
  • Bloody Diarrhea
  • +3 more
  • Bahia Blanca, Buenos Aires, Argentina
  • +6 more
Mar 28, 2022

Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

Recruiting
  • Antiphospholipid Syndrome
  • Thrombocytopenia
  • Anti-CD38 antibody Injection
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023

Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

Not yet recruiting
  • Renal Transplant Rejection
  • Induction Therapy
  • (no location specified)
Sep 22, 2022

ERT in Pompe Disease: Elucidation of Molecular Structures

Not yet recruiting
  • Pompe-Disease
    • Rüsselsheim, Hessen, Germany
      Centre for Analytical Biochemistry
    Jan 30, 2023

    Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in

    Recruiting
    • Polyclonal Hypergammaglobulinemia
    • Autoimmune Diseases
      • Amiens, France
        CHU Amiens
      Sep 28, 2023

      Colorectal Cancer Trial (Administration of CC-3)

      Not yet recruiting
      • Colorectal Cancer
      • Administration of CC-3
      • (no location specified)
      Aug 11, 2023

      Pediatric Induction Therapy in Kidney Transplantation

      Completed
      • Kidney Transplant Rejection
      • Pediatric Kidney Disease
      • Basiliximab Injection
      • rabbit ATG
      • Guangzhou, Guangdong, China
      • +4 more
      Oct 15, 2023

      Vitamin D Intervention in Infants - 6 Years Follow-up (VIDI2)

      Completed
      • Bone Strength
      • +5 more
        • Helsinki, Finland
          Children's Hospital
        Oct 31, 2022

        Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))

        Active, not recruiting
        • Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
        • Blinatumomab Expanded T-cells (BET)
        • Bergamo, Italy
          ASST - Papa Giovanni XXIII
        Dec 22, 2021

        Chronic Antibody-mediated Transplant Rejection Trial in Paris (Bortezomib, Plasma exchanges and intravenous immunoglobulins)

        Completed
        • Chronic Antibody-mediated Transplant Rejection
        • Bortezomib
        • Plasma exchanges and intravenous immunoglobulins
        • Paris, France
          Hopital Necker Enfants-malades
        Sep 14, 2020

        Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

        Recruiting
        • Solid Tumor
        • +15 more
        • RAPA-201 Rapamycin Resistant T Cells
        • Chemotherapy Prior to RAPA-201 Therapy
        • Hackensack, New Jersey
          Hackensack University Medical Center
        Dec 23, 2021

        Convalescent Plasma for COVID 19 Trial in Saudi Arabia (convalescent plasma from recovered COVID 19 donor)

        Completed
        • Convalescent Plasma for COVID 19
        • convalescent plasma from recovered COVID 19 donor
        • Dhahran, Eastern Provence, Saudi Arabia
        • +13 more
        Nov 14, 2021

        Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,

        Recruiting
        • Kidney Transplant
        • +3 more
        • Polyclonal Regulatory T Cells
        • +10 more
        • Birmingham, Alabama
        • +5 more
        Feb 22, 2022

        Metabolic Syndrome, Cardiovascular Risk Factor Trial in Athens (Probiotic mix, Placebo)

        Withdrawn
        • Metabolic Syndrome
        • Cardiovascular Risk Factor
        • Probiotic mix
        • Placebo
        • Athens, Greece
          Attikon University General Hospital
        Mar 30, 2022

        Healthy Trial (763SIP8/MPLA-5 vaccine)

        Not yet recruiting
        • Healthy
        • 763SIP8/MPLA-5 vaccine
        • (no location specified)
        Mar 15, 2023

        SARS Virus Trial in France, Martinique, Réunion (XAV-19, Placebo)

        Completed
        • SARS Virus
        • Amiens, France
        • +33 more
        Mar 24, 2022

        Drug Effect Trial in Ismailia (pulpotomy procedure and Histological evaluation, Immunohistochemistry Protocol for Fibronectin

        Recruiting
        • Drug Effect
        • pulpotomy procedure and Histological evaluation
        • +2 more
        • Ismailia, Egypt
          Suez Canal University
        May 26, 2022

        Gastrointestinal Tumors, Adenocarcinoma Trial in Worldwide (IMU-131, Cisplatin and either Fluorouracil (5-FU) or Capecitabine or

        Active, not recruiting
        • Gastrointestinal Neoplasms
        • Adenocarcinoma
        • IMU-131
        • Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine.
        • Tbilisi, Georgia
        • +21 more
        Jan 19, 2022

        Biomarkers of Metabolic Obesity.

        Completed
        • Obesity
          • Białystok, Poland
            Medical University of Bialystok
          Nov 3, 2022

          Peri-Implantitis Trial in Thessaloniki (Laser ,Fotona, Light Walker AT, Ljubljana, Slovenia, Mechanical Treatment)

          Completed
          • Peri-Implantitis
          • Laser ,Fotona, Light Walker AT, Ljubljana, Slovenia
          • Mechanical Treatment
          • Thessaloniki, Makedonia, Greece
            Aristotle University of Thessaloniki
          Feb 15, 2023